Agiliti Launches Essentia™: A Bed to Lower Risk & Boost Mobility
Proprietary safety features support advanced therapies across a wide range of patients and ease the burden on caregivers Agiliti, a leading manufacturer and provider of...
Category : Healthcare and Pharmaceutical
Aegis Launches Dashboard to Track Novel Psychoactive Substances
Aegis Sciences Corporation, a leader in toxicology and healthcare services, is excited to announce the launch of a groundbreaking data visualization dashboard designed to provide...
AdvanCell Partners with Lilly to Advance Targeted Alpha Therapies
AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an expansion to the scope and breadth of its strategic collaboration with Eli...
GeneDx Integrates with Epic to Advance Genome Sequencing Adoption
UNC Health to Become the First Health System to Collaborate with GeneDx Through Aura, Epic’s Specialty Diagnostic Suite GeneDx (Nasdaq: WGS), a leader in delivering...
Pfizer and Astellas’ PADCEV® + KEYTRUDA® Shows Long-Term Efficacy
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced additional follow-up results from the Phase 3...
Ingenovis Health Elevates Jan Ross to Chief Information Officer
Ingenovis Health today announced the promotion of Jan Ross to Chief Information Officer, effective immediately. Ross joined the company in March 2023 as Senior Vice...
Citruslabs: UK Wellness Brands Must Prioritise Science-backed Products
– Citruslabs, one of the leading CROs for consumer brands in the US, is expanding its services to the UK, which has a health and wellness...
IDEAYA Appoints Joshua Bleharski as CFO
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced the appointment of Joshua Bleharski, Ph.D....
Turacoz Transforms into Tech-Driven Solution for Medical Comm.
Turacoz highlights the growing integration of AI, human insight, and patient involvement in medical communications, while emphasizing the importance of integrity and transparency. With the...
Certis Oncology CEO Peter Ellman Presents at Precision Med Conf
Certis Oncology showcases recently launched AI/ML platforms for cancer therapeutics development and personalized medicine. Presentation highlights AI’s transformative role in precision medicine, features CertisAI Predictive...
AceLink Presents Phase 2 Results of AL01211 for Fabry Disease
AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim data from its ongoing Phase 2 clinical study of...
PHC and CCRM Partner to Improve T-Cell Expansion Processes
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell(*1) expansion culture processes that will seek to...
Response Pharma Completes Phase 2 Enrollment for RDX-002
Response Pharmaceuticals, Inc., a clinical-stage company focused on weight management and metabolic health in high-risk populations, today announced the early completion of enrollment in a...
Cencora Expands Drug Shortage Program to Strengthen Supply Chain
Marks significant expansion of initiative to help health systems access critical, at-risk medications for patients Cencora, a global healthcare company, has significantly expanded the number...
Cadrenal Therapeutics Announces CMO Transition for Tecarfarin
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapies, with the late-stage asset tecarfarin, a new Vitamin...